EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Kinase-independent signaling by PIM1 promotes drug resistance by increasing mitophagy and reducing oxidative stress

Hope Liou, Shailender S Chauhan, Caitlyn E Flores, Rose Kinkade, Madeline R Ressel, Anne E Cress, Paul R Langlais, Yogesh B Sutar, Abhijit A Date, Noel A Warfel

Cancer Letters · 2026-08 · 654 · 218611

DOI: 10.1016/j.canlet.2026.218611 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026-08. Verfasst von Hope Liou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Graduate Program, University of Arizona, Tucson, AZ, USA. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-pim-1, Mitophagy, Drug Resistance, Neoplasm, Oxidative Stress. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: US Department of Defense, University of Arizona, National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PIM kinases are overexpressed in castration resistant prostate cancer (CRPC) and many small molecule PIM kinase inhibitors (smPIM inhibitors) have been designed to block the catalytic activity of PIM. However, smPIM inhibitors have shown limited efficacy in solid tumors. Notably, all these inhibitors share the common property that they increase total PIM protein levels, which limits their efficacy because PIM1 has kinase-independent pro-survival effects. Here, we identify high mobility box group 1 (HMGB1) as a novel PIM1 binding partner. Stabilization of PIM1 by smPIM inhibitors increases the cytosolic accumulation of HMGB1, which leads to activation of mitophagy and suppresses oxidative-stress induced cell death. Knockdown of PIM1/2/3 and/or HMGB1 sensitizes cancer cells to smPIM inhibitors. In contrast, treatment with a PIM PROTAC (PIMTAC) that we developed overcomes the kinase-independent pro-survival effects of PIM1 and is more effective than smPIM inhibitors in vitro and in vivo. These results uncover a mechanism of resistance that has limited the success of smPIM inhibitors and provides compelling evidence that targeted degradation of PIM is needed to realize its potential as an anti-cancer target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-pim-1MitophagyDrug Resistance, NeoplasmOxidative StressProtein Kinase InhibitorsHumansAnimalsSignal TransductionCell Line, TumorMaleHMGB1 ProteinMiceProteolysis Targeting ChimeraProto-Oncogene ProteinsProtein Serine-Threonine Kinases

Stichwörter der Autor:innen

HMGB1MitophagyPIM inhibitorPIM1PROTACResistance

Substanzen

Proto-Oncogene Proteins c-pim-1PIM1 protein, humanProtein Kinase InhibitorsHMGB1 ProteinHMGB1 protein, humanProteolysis Targeting ChimeraPIM2 protein, humanPIM3 protein, humanProto-Oncogene ProteinsProtein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Cancer Biology Graduate Program, University of Arizona, Tucson, AZ, USA.
  • Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
  • Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA.
  • Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ, USA.
  • Department of Pharmacology and Toxicology, R. K. Coit College of Pharmacy, University of Arizona, Tucson, AZ, USA.
  • Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA. Electronic address: warfeln@MUSC.edu.

Förderung

  • US Department of Defense
  • University of Arizona
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Liou, H., Chauhan, S. S., Flores, C. E., Kinkade, R., Ressel, M. R., Cress, A. E., Langlais, P. R., Sutar, Y. B., Date, A. A., & Warfel, N. A. (2026). Kinase-independent signaling by PIM1 promotes drug resistance by increasing mitophagy and reducing oxidative stress. Cancer Letters, 654, 218611. https://doi.org/10.1016/j.canlet.2026.218611

Vancouver

Liou H, Chauhan SS, Flores CE, Kinkade R, Ressel MR, Cress AE, et al. Kinase-independent signaling by PIM1 promotes drug resistance by increasing mitophagy and reducing oxidative stress. Cancer Letters. 2026;654:218611. doi:10.1016/j.canlet.2026.218611

BibTeX
@article{Liou2026,
  author = {Liou, Hope and Chauhan, Shailender S and Flores, Caitlyn E and Kinkade, Rose and Ressel, Madeline R and Cress, Anne E and Langlais, Paul R and Sutar, Yogesh B and Date, Abhijit A and Warfel, Noel A},
  title = {Kinase-independent signaling by PIM1 promotes drug resistance by increasing mitophagy and reducing oxidative stress},
  journal = {Cancer Letters},
  year = {2026},
  volume = {654},
  pages = {218611},
  doi = {10.1016/j.canlet.2026.218611}
}
Kostenlos starten →